This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book
Key Sessions
James Powell
The History and Future of Oligonucleotide Manufacturing
Novo Nordisk
Vadim Dudkin, PhD
Novel Ligands for Cell Selective Gene Silencing
Soufflé Therapeutics
Kiran Musunuru, MD, PhD
Lessons Learned from a Personalized CRISPR Gene Editing Therapy
University of Pennsylvania
Michael Kopach, PhD
Retatrutide: A Breakthrough Triagonist Uniting Molecular Design and Sustainable Manufacturing
Eli Lilly and Company
Robert Langer, ScD
From Nanotechnology to Nucleic Acid Therapeutics: How Overcoming Skepticism and Barriers Led to New Cancer Treatments and Ways to Tackle a Global Health Challenge
Massachusetts Institute of Technology
Anastasia Khvorova, PhD
Chemical Innovation in RNAi: From Chemistry to Neurotherapeutic Applications
UMass Chan Medical School
Laura Sepp-Lorenzino, PhD
From Sequence to Therapy: Innovations in Oligonucleotide and Genome Editing Medicines
GNMmeds LLC
Ashok Bhandari, PhD
Precision Peptides, Powerful Impact: Protagonist Story of Peptide Innovation from Platform to Patients
Protagonist Therapeutics
keyboard_arrow_right

Main Conference - Day 1 Keynote Sessions (May 12)

keyboard_arrow_leftSearch & Filter
search
Main Conference - Day 1 Keynote Sessions (May 12)
search
6:30am - 7:30am
Registration
Breakfast Spotlight Presentations
Showing 3 of 3 Streams
7:30am - 8:00am
Balanced Chemistry in Peptide Therapeutics
  • Susan Li, PhD - Peptide Chief Scientist, Asymchem
7:30am - 8:00am
Cytiva Spotlight Presentation
7:30am - 8:00am
Driving Further Evolution in Peptide API Downstream Processing
  • Yoshitaka Nemoto - Vice President R&D, PeptiStar
Showing 1 of 1 Streams
8:10am - 8:15am
Chairperson’s Remarks: Keynote Day 1
8:15am - 9:00am
Retatrutide: A Breakthrough Triagonist Uniting Molecular Design and Sustainable Manufacturing
  • Michael Kopach, PhD - Associate Vice President, Synthetic Molecule Design and Development, Eli Lilly and Company
9:00am - 9:45am
Precision Peptides, Powerful Impact: Protagonist Story of Peptide Innovation from Platform to Patients
  • Ashok Bhandari, PhD - Executive Vice President, Chief Discovery Officer, Protagonist Therapeutics
9:45am - 10:15am
Networking Refreshment Break
Morning Keynote Session
Showing 1 of 1 Streams
10:15am - 11:00am
The History and Future of Oligonucleotide Manufacturing
  • James Powell - SVP, Manufacturing and Boulder Site Head, Novo Nordisk
11:00am - 11:45am
Chemical Innovation in RNAi: From Chemistry to Neurotherapeutic Applications
  • Anastasia Khvorova, PhD - Professor, RNA Therapeutics Institute, UMass Chan Medical School
11:45am - 12:05pm
Transition to Spotlight Presentation/Panel Luncheons
Spotlight Presentation Luncheons
Showing 6 of 6 Streams
12:05pm - 12:35pm
Nitto Avecia Luncheon Presentation
12:05pm - 12:35pm
Axolabs Luncheon Presentation
12:05pm - 12:35pm
Hongene Luncheon Presentation
  • David Butler, PhD - Chief Technology Officer, Hongene Biotech Corporation
12:05pm - 12:35pm
Improving CRISPR Genome Editing Efficiency by Optimized Manufacturing Methods for High-purity Modified gRNAs
  • Toshifumi Kano - Research Associate, Sumitomo Chemical Europe
12:05pm - 12:35pm
Supporting Clients from Pre-Clinic to Commercial: Using the Wigman Model to Strategize GMP Process Development
  • Amy Druschitz - Technical Business Development Manager, Croda
12:35pm - 12:55pm
Short Networking Break
Afternoon Keynote Session
Showing 1 of 1 Streams
12:55pm - 1:00pm
Chairperson’s Remarks: Keynote Day 1
1:00pm - 1:45pm
From Nanotechnology to Nucleic Acid Therapeutics: How Overcoming Skepticism and Barriers Led to New Cancer Treatments and Ways to Tackle a Global Health Challenge
  • Robert Langer, ScD - David H. Koch Institute Professor, Massachusetts Institute of Technology
1:45pm - 2:30pm
From Sequence to Therapy: Innovations in Oligonucleotide and Genome Editing Medicines
  • Laura Sepp-Lorenzino, PhD - Biotech Executive, Board Member and Industry Advisor, GNMmeds LLC
2:30pm - 3:30pm
Grand Opening of Poster and Exhibit Hall and Networking Refreshment Break
Showing 1 of 1 Streams
3:30pm - 4:15pm
Novel Ligands for Cell Selective Gene Silencing
  • Vadim Dudkin, PhD - Founding Chief Technology Officer, Soufflé Therapeutics
4:15pm - 5:00pm
Lessons Learned from a Personalized CRISPR Gene Editing Therapy
  • Kiran Musunuru, MD, PhD - Barry J. Gertz Professor for Translational Research, Perelman School of Medicine, University of Pennsylvania
5:00pm - 6:30pm
Networking Reception in Poster and Exhibit Halls
Pre-Conference Day (May 11)
NextMain Conference - Day 2 (May 13)
Filter
Streams
Choose Day